Published in Essays Neurochem Neuropharmacol on January 01, 1977
Bradykinin and oedema formation in heated paws of rats. Br J Pharmacol Chemother (1967) 2.11
Behavioural depressant and antinociceptive properties of substance P in the mouse: possible implication of brain monoamines. Eur J Pharmacol (1978) 1.40
Enzyme-potentiated hyposensitisation. I. The effect of pre-treatment with -glucuronidase, hyaluronidase, and antigen on anaphylactic sensitivity of guinea-pigs, rats and mice. Int Arch Allergy Appl Immunol (1972) 1.22
The effect of bradykinin and anti-inflammatory agents on isolated arteries. J Pharm Pharmacol (1966) 1.20
The uptake of ( 14 C) -aminobutyric acid by the isolated retina of the rat. Vision Res (1972) 1.19
Inhibition of anaphylactic shock in the rat by antihistamines and ascorbic acid. Br J Pharmacol Chemother (1966) 1.11
GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum. Eur J Pharmacol (1978) 1.06
Studies in pollen allergy. 3. The relationship between blocking antibody levels and symptomatic relief following hyposensitisation with allpyral in hay fever subjects. Int Arch Allergy Appl Immunol (1970) 1.03
Effects of prostaglandins and a prostaglandin antagonist on intraocular pressure and protein in the monkey eye. Can J Ophthalmol (1971) 0.98
Further studies on the effect of prostaglandin on intraocular pressure in the rabbit. Exp Eye Res (1971) 0.92
Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors. Neuropharmacology (1986) 0.90
Effects of prostaglandin on blood flow in the rabbit eye. Exp Eye Res (1971) 0.89
The efflux of radioactive GABA from rat retina in vitro. Vision Res (1972) 0.89
Evidence for the participation of nigrotectal gamma-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat. Neuroscience (1982) 0.88
Effect of inhibitors of -aminobutyrate aminotransferase on the accumulation of 3H- -aminobutyric acid by the retina. Br J Pharmacol (1973) 0.88
Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice. Neuropharmacology (1987) 0.82
Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase. Amino Acids (1998) 0.82
Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice. Pharmacol Biochem Behav (1990) 0.82
Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection. Eur J Pharmacol (1981) 0.81
Studies in pollen allergy. I. A method for estimating histamine release from sensitised leucocytes in the presence of serum. Int Arch Allergy Appl Immunol (1970) 0.81
Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studies. Exp Brain Res (1980) 0.80
Evidence for the compartmentation of glutamate metabolism in isolated rat retina. J Neurochem (1974) 0.80
Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra. Neurosci Biobehav Rev (1997) 0.80
Motor depression: a new role for D1 receptors? Neuroscience (1990) 0.80
Effect of dark adaptation on the GABA system in retina. Brain Res (1973) 0.79
SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors. Eur J Pharmacol (1985) 0.79
Effects of amino-oxyacetic acid, ethanolamine-O-sulphate and GABA on the contents of GABA and various amines in brain slices. J Neurochem (1975) 0.79
Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat. J Pharm Pharmacol (1977) 0.79
Evidence for a GABAergic nigrothalamic pathway in the rat. II. Electrophysiological studies. Exp Brain Res (1980) 0.79
Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent. Neuroscience (2000) 0.78
Behavioural role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience (1987) 0.78
Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours. Neuroscience (1987) 0.78
Nigral-derived muscimol circling--ipsiversive, contraversive or controversial? Nature (1981) 0.78
Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. J Pharm Pharmacol (1980) 0.78
GABA-mediated potentiation of amine release from nigrostriatal dopamine neurones in vitro. Eur J Pharmacol (1979) 0.78
Uptake of taurine by retina in different species. Brain Res (1978) 0.78
Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience (1993) 0.78
Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience (1997) 0.77
Is the animal's defence against injury and allergic phenomena linked with resistance to the anaphylactoid reaction? Int Arch Allergy Appl Immunol (1967) 0.77
Role of the ventromedial nucleus of the thalamus in motor behaviour--I. Effects of focal injections of drugs. Neuroscience (1983) 0.77
Muscarinic action of acetylcholine in the rat ventromedial thalamic nucleus. Exp Brain Res (1984) 0.77
Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion. Neuroscience (1987) 0.77
Is glycine an inhibitory synaptic transmitter in the substantia nigra? Eur J Pharmacol (1979) 0.77
The effects of various amino acids, dopamine and some convulsants on the electroretinogram of the rabbit. Exp Eye Res (1975) 0.77
Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Res (1997) 0.77
Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology (1990) 0.77
Haemorrhagic, traumatic and tourniquet shock in the rat. J Pharm Pharmacol (1967) 0.77
D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharmacol Biochem Behav (1991) 0.77
Regional changes in brain dopamine utilization during status epilepticus in the rat induced by systemic pilocarpine and intrahippocampal carbachol. Neuropharmacology (1996) 0.77
Implantation of dihydrotestosterone propionate into the lateral septum or medial amygdala facilitates copulation in castrated male rats given estradiol systemically. Horm Behav (1982) 0.77
Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390. Pharmacol Biochem Behav (1986) 0.77
The uptake, metabolism and release of 14C-taurine by rat retina in vitro. Vision Res (1972) 0.77
Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. J Neural Transm Park Dis Dement Sect (1992) 0.77
Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain. Brain Res (2000) 0.77
Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid. Eur J Pharmacol (1999) 0.76
Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis. J Neural Transm Park Dis Dement Sect (1993) 0.76
Effects of substance P injected into the substantia nigra. Br J Pharmacol (1979) 0.76
Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse. Eur J Pharmacol (1995) 0.76
Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions. Neuroscience (1983) 0.76
Brain dopamine activity following intranigral or intrathalamic drug injections in the rat. Brain Res Bull (1985) 0.76
Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits? Neuroscience (1991) 0.76
NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats. Eur J Pharmacol (1996) 0.76
Antagonists of glutamate in the treatment of Parkinson's disease: from laboratory to the clinic. Amino Acids (1998) 0.76
Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Synapse (1999) 0.76
Putative neurotoxicity of SKF 38393 and other D1 dopaminergic drugs investigated in rat striatum. J Neurochem (1992) 0.76
Potentiation by substance P of contractions of the isolated vas deferens of the mouse elicited by electric field stimulation and by drugs. Br J Pharmacol (1978) 0.75
Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat. Neuroscience (1994) 0.75
Effect of amino-oxyacetic acid on the accumulation of 3H- -aminobutyric acid (3H-GABA) by rat retina. Br J Pharmacol (1973) 0.75
Impulse-dependent and tetrodotoxin-sensitive release of GABA in the rat's substantia nigra measured by microdialysis. Brain Res (1995) 0.75
Further evidence for the involvement of kinin in anaphylactic shock in the rat. Br J Pharmacol (1969) 0.75
D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice. Neuroreport (1993) 0.75
The importance of plasma kinins in the anaphylactoid reaction in rats. Br J Pharmacol Chemother (1967) 0.75
The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra. Synapse (1998) 0.75
Dysfunction of the midbrain angular complex can accentuate or attenuate circling behaviour in the rat. Exp Brain Res (1985) 0.75
Interactions between dopamine and gamma-aminobutyrate in the substantia nigra: implications for the striatonigral output hypothesis. Neuroscience (1983) 0.75
Further studies on the process of histamine release from sensitized guinea-pig bone marrow basophils by antigen. Int Arch Allergy Appl Immunol (1970) 0.75
Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol Biochem Behav (1990) 0.75
Effects of metabolic inhibitors on amino acid metabolism in rat retina: a comparison of amino-oxyacetic acid and ethanolamine-o-sulphate. J Neurochem (1975) 0.75
Multiple opiate receptors may be involved in suppressing gamma-aminobutyrate release in substantia nigra. Life Sci (1985) 0.75
Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse. J Neural Transm Park Dis Dement Sect (1994) 0.75
A comparative study of the utilization of glucose, acetate, glutamine and GABA as precursors of amino acids by retinal of the rat, frog, rabbit and pigeon. Biochem Pharmacol (1975) 0.75
Multifocal brain sites for apomorphine-induced circling and other stereotyped motor behaviour in the 6-hydroxydopamine-lesioned rat. Neurosci Lett (1982) 0.75
Distribution of gamma-aminobutyrate in the rat thalamus: specific decreases in thalamic gamma-aminobutyrate following lesion or electrical stimulation of the substantia nigra. Neuroscience (1981) 0.75
Specificity of GABA as a stimulator of dopamine release in rat substantia nigra. Neurosci Lett (1980) 0.75
Evidence for the involvement of nigrothalamic GABA neurons in circling behaviour in the rat. Adv Biochem Psychopharmacol (1981) 0.75
Bilateral asymmetry in brain GABA function? Neurosci Lett (1981) 0.75
Relationship between blocking antibody titres and symptomatic relief in hay-fever subjects treated with allpyral. Int Arch Allergy Appl Immunol (1971) 0.75
Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors. Eur J Pharmacol (1992) 0.75
Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease? J Neural Transm (Vienna) (1996) 0.75
The role of GABA in the substantia nigra. Nature (1978) 0.75
Effects of changes in the ionic composition of the incubation medium on the accumulation and metabolism of 3 H- -aminobutyric acid and 14 C-taurine in isolated rat retina. Biochem Pharmacol (1973) 0.75
The nucleus tegmenti pedunculopontinus and circling behaviour in the rat. Neurosci Lett (1981) 0.75
Anticonvulsant action of SCH 23390 in the striatum of the rat. Eur J Pharmacol (1990) 0.75
Proconvulsant effect of SKF 38393 mediated by nigral D1 receptors. Eur J Pharmacol (1990) 0.75
Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice. Exp Brain Res (1994) 0.75
CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse. Pharmacol Biochem Behav (1991) 0.75
Investigation of possible interactions between substance P and transmitter mechanisms in the substantia nigra and corpus striatum of the rat. J Pharm Pharmacol (1978) 0.75
Inhibition of sexual behavior by dopamine antagonist or serotonin agonist drugs in castrated male rats given estradiol or dihydrotestosterone. Pharmacol Biochem Behav (1980) 0.75
Inability of dextran to release kinin in rats. J Pharm Pharmacol (1970) 0.75